We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 10,000 results
  1. Hemophagocytic Lymphohistiocytosis for the Inpatient Dermatologist

    Hemophagocytic lymphohistiocytosis (HLH) is a potentially life-threatening condition characterized by dysregulation of the immune system leading to...

    Bliss Colao, Grace Hingtgen, ... Kiran Motaparthi in Current Dermatology Reports
    Article 12 July 2024
  2. Correlation between serum cardiac troponin I level and PDAI score in patients with pemphigus vulgaris

    Pemphigus vulgaris (PV) is a rare, yet serious autoimmune disorder primarily affecting the skin and mucous membranes. While the dermatological and...

    Zeinab Aryanian, Safoura shakoei, ... Parvaneh Hatami in Archives of Dermatological Research
    Article 11 July 2024
  3. Crosstalk between gut–brain axis: unveiling the mysteries of gut ROS in progression of Parkinson’s disease

    “Path to a good mood lies through the gut.” This statement seems to imply that it has long been believed that the gut is connected with the brain....

    Divya Soni, Shubham Upadhayay, ... Puneet Kumar in Inflammopharmacology
    Article 11 July 2024
  4. Infantile systemische Hyalinose

    Conrad Hempel, Olga Hempel in Die Dermatologie
    Article 10 July 2024
  5. The Impact of Artificial Intelligence on Health Equity in Dermatology

    Purpose of this Review

    Artificial intelligence (AI) refers to a technology in which a machine is able to perform a task simulating human intelligence....

    Fatuma-Ayaan Rinderknecht, Lotanna Nwandu, ... Roxana Daneshjou in Current Dermatology Reports
    Article 10 July 2024
  6. Fibroblast growth factor receptor 4 deficiency in macrophages aggravates experimental colitis by promoting M1-polarization

    Objective and design

    Compelling evidence indicates that dysregulated macrophages may play a key role in driving inflammation in inflammatory bowel...

    Luyao Shen, Cong Wang, ... Yongsheng Li in Inflammation Research
    Article 10 July 2024
  7. Efficacy and safety of infliximab and adalimumab in inflammatory bowel disease patients

    Introduction

    Inflammatory bowel disease (IBD), consists of two primary types: Ulcerative Colitis (UC) and Crohn’s Disease (CD). Infliximab (IFX) and...

    Mahmoud E. Kamal, Rehab H. Werida, ... Radwa S. Hagag in Inflammopharmacology
    Article Open access 10 July 2024
  8. Global, regional, and national burdens of atopic dermatitis under 14: a trend analysis and future prediction based on the global burden of disease study 2019

    Objective

    The aim is to evaluate the global, regional, and national trends in the burden of children and adolescents under 14 from 1990 to 2019, as...

    Zhiqin Wang, **aofeng Liang, ... **uzhong Gao in Archives of Dermatological Research
    Article 10 July 2024
  9. New studies with stable gastric pentadecapeptide protecting gastrointestinal tract. significance of counteraction of vascular and multiorgan failure of occlusion/occlusion-like syndrome in cytoprotection/organoprotection

    Since the early 1990s, when Robert’s and Szabo’s cytoprotection concept had already been more than one decade old, but still not implemented in...

    Predrag Sikiric, Marko Sever, ... Sven Seiwerth in Inflammopharmacology
    Article 09 July 2024
  10. Protective effects of ginsenosides on ulcerative colitis: a meta-analysis and systematic review to reveal the mechanisms of action

    Background

    Ulcerative colitis (UC) is a chronic inflammatory disease of the colon. Ginsenoside may be an ideal agent for UC treatment. However, its...

    Lingling Yuan, Wei Li, ... Yi Zhang in Inflammopharmacology
    Article 09 July 2024
  11. Lichen Planus: What is New in Diagnosis and Treatment?

    Lichen planus (LP), an idiopathic, multifaceted chronic inflammatory disease with a heterogeneous clinical presentation, affects approximately 0.5–1%...

    Burak Tekin, Fangyi **e, Julia S. Lehman in American Journal of Clinical Dermatology
    Article 09 July 2024
  12. Plattenepithelkarzinom der Haut

    Cutaneous squamous cell carcinoma (cSCC) is the second most common malignant skin tumor after basal cell carcinoma, accounting for approximately 20%...

    Maximilian Krecu, Peter Kölblinger in hautnah
    Article Open access 09 July 2024
  13. Development of the Cutaneous Dermatomyositis Investigator Global Assessment (CDM-IGA): A De Novo IGA of Cutaneous Manifestations of Dermatomyositis

    Introduction

    Dermatomyositis (DM) is a rare systemic autoimmune disease characterized by a distinctive debilitating skin rash and skeletal muscle...

    Stephanie McKee, Jason Xenakis, ... Sarah L. Knight in Dermatology and Therapy
    Article Open access 08 July 2024
  14. Global burden of skin and subcutaneous diseases and its association with socioeconomic status in children and adolescents: an analysis of the Global Burden of Diseases Study 2019

    Skin and subcutaneous diseases are one of the most common problems affecting the health of children and adolescents. The purpose of this study was to...

    Meina Lv, Bin Zheng in Archives of Dermatological Research
    Article 05 July 2024
Did you find what you were looking for? Share feedback.